[HTML][HTML] Discovery and development of safe-in-man broad-spectrum antiviral agents

PI Andersen, A Ianevski, H Lysvand… - International Journal of …, 2020 - Elsevier
Viral diseases are one of the leading causes of morbidity and mortality in the world. Virus-specific
vaccines and antiviral drugs are the most powerful tools to combat viral diseases. …

Novel activities of safe-in-human broad-spectrum antiviral agents

…, E Zusinaite, S Kuivanen, M Strand, H Lysvand… - Antiviral research, 2018 - Elsevier
According to the WHO, there is an urgent need for better control of viral diseases. Re-positioning
existing safe-in-human antiviral agents from one viral disease to another could play a …

[HTML][HTML] Potential antiviral options against SARS-CoV-2 infection

…, S Biza, E Zusinaite, T Reisberg, H Lysvand… - Viruses, 2020 - mdpi.com
As of June 2020, the number of people infected with severe acute respiratory coronavirus 2 (SARS-CoV-2)
continues to skyrocket, with more than 6.7 million cases worldwide. Both the …

[HTML][HTML] Identification and tracking of antiviral drug combinations

…, N Shtaida, E Kulesskiy, E Jo, J Yang, H Lysvand… - Viruses, 2020 - mdpi.com
Combination therapies have become a standard for the treatment for HIV and hepatitis C
virus (HCV) infections. They are advantageous over monotherapies due to better efficacy, …

[HTML][HTML] Synergistic interferon-alpha-based combinations for treatment of SARS-CoV-2 and other viral infections

…, S Wang, E Jo, J Yang, E Ravlo, W Wang, H Lysvand… - Viruses, 2021 - mdpi.com
Background: There is an urgent need for new antivirals with powerful therapeutic potential
and tolerable side effects. Methods: Here, we tested the antiviral properties of interferons (IFNs…

[HTML][HTML] Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases

OJ Iversen, H Lysvand, G Slupphaug - Clinical Immunology, 2017 - Elsevier
Autoimmune diseases are characterized by chronic inflammatory reactions localized to an
organ or organ-system. They are caused by loss of immunologic tolerance toward self-…

[HTML][HTML] Nafamostat–interferon-α combination suppresses SARS-CoV-2 infection in vitro and in vivo by cooperatively targeting host TMPRSS2

A Ianevski, R Yao, H Lysvand, G Grødeland, N Legrand… - Viruses, 2021 - mdpi.com
SARS-CoV-2 and its vaccine/immune-escaping variants continue to pose a serious threat to
public health due to a paucity of effective, rapidly deployable, and widely available …

A novel SimpleProbe PCR assay for detection of mutations in the 23S rRNA gene associated with macrolide resistance in Mycoplasma genitalium in clinical samples

M Gossé, H Lysvand, B Pukstad… - Journal of clinical …, 2016 - Am Soc Microbiol
Macrolide-resistant strains of Mycoplasma genitalium are an increasing problem throughout
the world, and the implementation of a rapid and sensitive assay for mutation detection to …

[HTML][HTML] Chemical, physical and biological triggers of evolutionary conserved Bcl-xL-mediated apoptosis

…, M Bugge, E Zusinaite, V Oksenych, H Lysvand… - Cancers, 2020 - mdpi.com
Background: The evidence that pan-Bcl-2 or Bcl-xL-specific inhibitors prematurely kill virus-infected
or RNA/DNA-transfected cells provides rationale for investigating these apoptotic …

[HTML][HTML] Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study

A Ianevski, R Yao, E Zusinaite, H Lysvand, V Oksenych… - Viruses, 2021 - mdpi.com
Background: Every year, millions of people are hospitalized and thousands die from influenza
A virus (FLUAV) infection. Most cases of hospitalizations and death occur among the …